STATISTISCHE AUSWERTUNG MIKROBIOLOGISCHER WERTBESTIMMUNGEN VON ANTIBIOTIKA AUF PROGRAMMIERBAREN HP 67/97-TASCHENRECHNERN = EVALUATION STATISTIQUE DES DETERMINATIONS MICROBIOLOGIQUES DES ANTIBIOTIQUES SUR DES CALCULATEURS DE POCHE HP 67/97 PROGRAMMABLESSTEINIJANS V; HEIN H.1979; PHARM. INDUSTR.; DEU; DA. 1979; VOL. 41; NO 9; PP. 877-880; ABS. ENG; BIBL. 4 REF.Article

Pharmacokinetic characteristics of controlled release products and their biostatistical analysisSTEINIJANS, V. W.Paperback APV. 1989, Vol 22, pp 99-115, issn 0720-3543Article

TIEREXPERIMENTELLE UNTERSUCHUNGEN UEBER DEN EINFLUSS DES ANTIHYPERTENSIVUMS URAPIDIL AUF DEN KREISLAUF UND DIE KREISLAUFREGULATION. = RECHERCHES EXPERIMENTALES CHEZ L'ANIMAL SUR L'INFLUENCE DE L'ANTIHYPERTENSIF URAPIDIL SUR LA CIRCULATION ET LA REGULATION DE LA CIRCULATIONSCHOETENSACK W; BISCHLER P; DITTMANN EC et al.1977; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1977; VOL. 27; NO 10; PP. 1908-1919; ABS. ANGL.; BIBL. 21 REF.Article

International harmonization of regulatory bioequivalence requirementsSTEINIJANS, V. W; HAUSCHKE, D.Clinical research and regulatory affairs. 1993, Vol 10, Num 4, pp 203-220, issn 1060-1333Article

Update on the statistical analysis of bioequivalence studiesSTEINIJANS, V. W; HAUSCHKE, D.International journal of clinical pharmacology, therapy and toxicology (1980). 1990, Vol 28, Num 3, pp 105-110, issn 0174-4879Article

INHIBITION OF GLUCONEOGENESIS IN ISOLATED PERFUSED RAT LIVER BY CLANOBUTINWOLF H; SCHLEPPER J; STEINIJANS V et al.1980; BIOCHEM. PHARMACOL.; GBR; DA. 1980; VOL. 29; NO 12; PP. 1649-1652; BIBL. 25 REF.Article

Striving for standards in bioequivalence assessment : a reviewSCHULZ, H.-U; STEINIJANS, V. W.International journal of clinical pharmacology, therapy and toxicology (1980). 1991, Vol 29, Num 8, pp 293-298, issn 0174-4879, 6 p.Article

Equivalence concepts in clinical trialsSTEINIJANS, V. W; NEUHÄUSER, M; BRETZ, F et al.European journal of drug metabolism and pharmacokinetics. 2000, Vol 25, Num 1, pp 38-40, issn 0378-7966Article

Sample size determination : extended tables for the multiplicative model and bioequivalence ranges of 0.9 to 1.11 and 0.7 to 1.43DILETTI, E; HAUSCHEKE, D; STEINIJANS, V. W et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1992, Vol 30, Num 8, pp 287-290, issn 0174-4879Conference Paper

Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosingSCHULZ, H.-U; STEINIJANS, V. W; GABEL, H et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1984, Vol 22, Num 11, pp 621-625, issn 0174-4879Article

Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levelsSTEINIJANS, V. W; ZECH, K; FISCHER, R et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1983, Vol 21, Num 12, pp 624-630, issn 0174-4879Article

A note on Welch's approximate t-solution to bioequivalence assessmentHAUSCHKE, D; STEINIJANS, V. W; HOTHORN, L. A et al.Biometrika. 1996, Vol 83, Num 1, pp 236-237, issn 0006-3444Article

Measurements of morning and evening airflow grossly underestimate the circadian variability of FEV₁ and peak expiratory flow rate in asthmaD'ALONZO, G. E; STEINIJANS, V. W; KELLER, A et al.American journal of respiratory and critical care medicine. 1995, Vol 152, Num 3, pp 1097-1099, issn 1073-449XArticle

Sample size determination for bioequivalence assessment by means of confidence intervalsDILETTI, E; HAUSCHKE, D; STEINIJANS, V. W et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1992, Vol 30, pp S51-S58, issn 0174-4879, SUP1Article

Sample size determination : extended tables for the multiplicative model and bioequivalence ranges of 0.9 to 1.11 and 0.7 to 1.43DILETTI, E; HAUSCHKE, D; STEINIJANS, V. W et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1992, Vol 30, pp S59-S62, issn 0174-4879, SUP1Article

Galenical development of a new sustained-release theophylline pellet formulation for once-daily administrationBENEDIKT, G; STEINIJANS, V. W; DIETRICH, R et al.Arzneimittel-Forschung. 1988, Vol 38, Num 8, pp 1203-1209, issn 0004-4172Article

Striving for standards in bioequivalence assessment : a reviewSCHULZ, H. U; STEINIJANS, V. W.International journal of clinical pharmacology, therapy and toxicology (1980). 1992, Vol 30, pp S1-S6, issn 0174-4879, SUP1Article

Bioäquivalenz von per os applizierten Retard-Arzneimitteln: Konzeption der Studien und Entscheidung über Austauschbarkeit = Bioéquivalence des formes orales à libération contrôlée: Etude des concepts et décision à propos de leur substitution au cours d'un traitement médicamenteux = Bioequivalence of oral controlled release products: Study concept and decision about their substitution under drug therapyBLUME, H; SIEWERT, M; STEINIJANS, V et al.Pharmazeutische Industrie. 1989, Vol 51, Num 9, pp 1025-1033, issn 0031-711XArticle

Theophylline therapeutics drug monitoring in the case of a new sustained-release pellet formulation for once-daily evening administrationSTEINIJANS, V. W; TRAUTMANN, H; SAUTER, R et al.Annual review of chronopharmacology. 1990, Vol 7, pp 323-326, issn 0743-9539, 4 p.Conference Paper

Controversies in bioequivalence studiesSTEINIJANS, V. K; HAUSCHKE, D; JONKMAN, J. H. G et al.Clinical pharmacokinetics. 1992, Vol 22, Num 4, pp 247-253, issn 0312-5963Article

Sample size determination for bioequivalence assessment using a multiplicative modelHAUSCHKE, D; STEINIJANS, V. W; DILETTI, E et al.Journal of pharmacokinetics and biopharmaceutics. 1992, Vol 20, Num 5, pp 557-561, issn 0090-466XArticle

Feasibility of in-vitro/in-vivo correlation in the case of a new sustained-release theophylline pellet formulationDIETRICH, R; BRAUSSE, R; BENEDIKT, G et al.Arzneimittel-Forschung. 1988, Vol 38, Num 8, pp 1229-1237, issn 0004-4172Article

The evaluation of multiple clinical endpoints, with application to asthmaNEUHÄUSER, M; STEINIJANS, V. W; BRETZ, F et al.Drug information journal. 1999, Vol 33, Num 2, pp 471-477, issn 0092-8615Conference Paper

International harmonization of regulatory requirements for average bioequivalence and current issues in individual bioequivalenceSTEINIJANS, V. W; HAUSCHKE, D; SCHALL, R et al.Drug information journal. 1995, Vol 29, Num 3, pp 1055-1062, issn 0092-8615Conference Paper

Choice of characteristics and their bioequivalence ranges for the comparison of absorption rates of immediate-release drug formulationsSCHALL, R; LUUS, H. G; STEINIJANS, V. W et al.International journal of clinical pharmacology and therapeutics. 1994, Vol 32, Num 7, pp 323-328, issn 0946-1965Article